GileadGilead Sciences’ procurement division is developing a new roadmap for success and savings.  

By Kat Zeman, Senior Editor at Knighthouse Publishing 

Andy Murray walked in with a mission and a vision. Although Gilead Sciences had a distinguished reputation in the research and development of pharmaceutical drugs used in the treatment of HIV, hepatitis B, hepatitis C and influenza, the company was lacking in procurement best practices. 

Agios picAgios Pharmaceuticals launches its first wholly owned precision medicine, TIBSOVO, in record time thanks to its highly-integrated supply chain. 

By Janice Hoppe-Spiers, Senior Editor at Knighthouse Publishing

Agios Pharmaceuticals specializes in applying scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. In addition to celebrating its 10th anniversary this year, Agios achieved another major milestone in July when it received FDA approval on TIBSOVO, the biopharmaceutical company’s first wholly owned drug, and its second approved medicine from its internal research program within the last year. 


Banner HealthBanner Health’s supply chain department plays a large role in the organization’s mission to improve patients’ lives.
By Jim Harris, Senior Editor at Knighthouse Media

During its nearly 20 years of existence, Banner Health has gone through two distinct phases in its business. For its first decade, the Phoenix-based health system focused on providing acute care to patients. 

Starting in 2010, its focus shifted to being about clinical quality. During this period, Banner Health’s supply chain operations integrated input from physicians into its contracting, procurement and distribution processes, Vice President of Supply Chain Doug Bowen says.

Page 1 of 12

Current Issue

Check out our latest Edition!


Contact Us

Supply Chain World Magazine
150 N. Michigan Ave., Suite 900
Chicago, IL 60601


Click here for a full list of contacts.

Latest Edition

Spread The Love

Back To Top